Search Page

1

Cite

Share

New trends in lysophospholipid research.

Tigyi G. Tigyi G. Biochim Biophys Acta. 2013 Jan;1831(1):1. doi: 10.1016/j.bbalip.2012.09.011. Epub 2012 Sep 23. Biochim Biophys Acta. 2013. PMID: 23010474 Review. No abstract available.

Cite

Share

2

Cite

Share

LPA₁ receptor-mediated thromboxane A₂ release is responsible for lysophosphatidic acid-induced vascular smooth muscle contraction.

Dancs PT, Ruisanchez É, Balogh A, Panta CR, Miklós Z, Nüsing RM, Aoki J, Chun J, Offermanns S, Tigyi G, Benyó Z. Dancs PT, et al. Among authors: tigyi g. FASEB J. 2017 Apr;31(4):1547-1555. doi: 10.1096/fj.201600735R. Epub 2017 Jan 9. FASEB J. 2017. PMID: 28069828 Free PMC article.

Cite

Share

3

Cite

Share

Optical Control of Lysophosphatidic Acid Signaling.

Morstein J, Dacheux MA, Norman DD, Shemet A, Donthamsetti PC, Citir M, Frank JA, Schultz C, Isacoff EY, Parrill AL, Tigyi GJ, Trauner D. Morstein J, et al. Among authors: tigyi gj. J Am Chem Soc. 2020 Jun 17;142(24):10612-10616. doi: 10.1021/jacs.0c02154. Epub 2020 Jun 5. J Am Chem Soc. 2020. PMID: 32469525 Free PMC article.

Cite

Share

4

Cite

Share

Regulation of Tumor Immunity by Lysophosphatidic Acid.

Lee SC, Dacheux MA, Norman DD, Balázs L, Torres RM, Augelli-Szafran CE, Tigyi GJ. Lee SC, et al. Among authors: tigyi gj. Cancers (Basel). 2020 May 10;12(5):1202. doi: 10.3390/cancers12051202. Cancers (Basel). 2020. PMID: 32397679 Free PMC article. Review.

Cite

Share

5

Cite

Share

Revisiting the role of lysophosphatidic acid in stem cell biology.

Tigyi G, Lin KH, Jang IH, Lee SC. Tigyi G, et al. Exp Biol Med (Maywood). 2021 Aug;246(16):1802-1809. doi: 10.1177/15353702211019283. Epub 2021 May 26. Exp Biol Med (Maywood). 2021. PMID: 34038224 Review.

Cite

Share

6

Cite

Share

Role of autotaxin in cancer stem cells.

Lee D, Suh DS, Lee SC, Tigyi GJ, Kim JH. Lee D, et al. Among authors: tigyi gj. Cancer Metastasis Rev. 2018 Sep;37(2-3):509-518. doi: 10.1007/s10555-018-9745-x. Cancer Metastasis Rev. 2018. PMID: 29926310 Free PMC article. Review.

Cite

Share

7

Cite

Share

Anti-cancer strategies targeting the autotaxin-lysophosphatidic acid receptor axis: is there a path forward?

Tigyi G, Dacheux MA, Lin KH, Yue J, Norman D, Benyó Z, Lee SC. Tigyi G, et al. Cancer Metastasis Rev. 2021 Mar;40(1):3-5. doi: 10.1007/s10555-021-09955-5. Cancer Metastasis Rev. 2021. PMID: 33454844 Free PMC article. No abstract available.

Cite

Share

8

Cite

Share

Dysregulation of lysophospholipid signaling by p53 in malignant cells and the tumor microenvironment.

Lee SC, Lin KH, Balogh A, Norman DD, Bavaria M, Kuo B, Yue J, Balázs L, Benyó Z, Tigyi G. Lee SC, et al. Among authors: tigyi g. Cell Signal. 2021 Feb;78:109850. doi: 10.1016/j.cellsig.2020.109850. Epub 2020 Nov 28. Cell Signal. 2021. PMID: 33253914 Free PMC article. Review.

Cite

Share

9

Cite

Share

Controlling cancer through the autotaxin-lysophosphatidic acid receptor axis.

Gotoh M, Fujiwara Y, Yue J, Liu J, Lee S, Fells J, Uchiyama A, Murakami-Murofushi K, Kennel S, Wall J, Patil R, Gupte R, Balazs L, Miller DD, Tigyi GJ. Gotoh M, et al. Among authors: tigyi gj. Biochem Soc Trans. 2012 Feb;40(1):31-6. doi: 10.1042/BST20110608. Biochem Soc Trans. 2012. PMID: 22260662 Free PMC article. Review.

Cite

Share

10

Cite

Share

MicroRNA trafficking and human cancer.

Yue J, Tigyi G. Yue J, et al. Among authors: tigyi g. Cancer Biol Ther. 2006 Jun;5(6):573-8. doi: 10.4161/cbt.5.6.2872. Epub 2006 Jun 2. Cancer Biol Ther. 2006. PMID: 16760647 Review.

Cite

Share